Effect of Olfactory Stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD
- PMID: 31981567
- DOI: 10.1016/j.chest.2019.12.028
Effect of Olfactory Stimulation by L-Menthol on Laboratory-Induced Dyspnea in COPD
Abstract
Background: Inhalation of L-menthol as a transient receptor potential melastatin 8 agonist induces a cooling sensation in the airway. This cooling sensation induced through olfactory stimulation by L-menthol (OSM) alleviates dyspnea in healthy humans. Therefore, we investigated effects of OSM on the neural respiratory drive (NRD) and multidimensional aspects of dyspnea induced by inspiratory resistive loaded breathing in COPD.
Methods: In total, 28 patients with COPD and 14 control participants were included in this randomized, single-blinded, placebo-controlled, crossover study. OSM was administered using an L-menthol-scented patch, whereas placebo was administered using olfactory stimulation by strawberry-scented patch: placebo (OSP). Sham condition was measured by breathing through a face mask without a OSP. Dyspnea was evoked by breathing through the inspiratory resistance of 20 or 30 cm H2O/L/s and measured using the Multidimensional Dyspnea Profile. NRD was estimated using the electromyogram activities of the parasternal intercostal muscles.
Results: Compared with sham and OSP, OSM did not alter the breathing pattern/timing and NRD during inspiratory resistive loading; however, it significantly alleviated the physical and mental breathing effort, air hunger, breathing discomfort, anxiety, and fear during inspiratory resistive loaded breathing in patients with COPD. However, although OSM reduced the air hunger, mental breathing effort, and unpleasantness, no significant improvement on affective dimension of dyspnea by OSM was observed in control participants.
Conclusions: Our findings suggest that OSM activated the sense of inspiratory flow that achieved dyspnea relief in patients with COPD.
Trial registry: UMIN Clinical Trials Registry (UMIN-CTR); No.: UMIN000033822; URL: https://www.umin.ac.jp/ctr/index.htm.
Keywords: COPD; L-menthol; TRPM8; cognition of inspiratory flow; dyspnea.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Comment in
-
Breathlessness Isn't Cool, But Its Treatment Can Be.Chest. 2020 Jun;157(6):1401-1402. doi: 10.1016/j.chest.2020.02.052. Chest. 2020. PMID: 32505299 No abstract available.
Similar articles
-
Nasal inhalation of l-menthol reduces respiratory discomfort associated with loaded breathing.Am J Respir Crit Care Med. 1997 Jul;156(1):309-13. doi: 10.1164/ajrccm.156.1.9609059. Am J Respir Crit Care Med. 1997. PMID: 9230767 Clinical Trial.
-
Inspiratory muscle training reduces diaphragm activation and dyspnea during exercise in COPD.J Appl Physiol (1985). 2018 Aug 1;125(2):381-392. doi: 10.1152/japplphysiol.01078.2017. Epub 2018 Mar 15. J Appl Physiol (1985). 2018. PMID: 29543134 Clinical Trial.
-
[Does the inhalation of a 1% L-menthol solution in the premedication of fiberoptic bronchoscopy affect coughing and the sensation of dyspnea?].Pneumologie. 2001 Mar;55(3):115-9. doi: 10.1055/s-2001-12280. Pneumologie. 2001. PMID: 11303537 Clinical Trial. German.
-
l-Menthol - a new treatment for breathlessness?Curr Opin Support Palliat Care. 2021 Dec 1;15(4):233-238. doi: 10.1097/SPC.0000000000000569. Curr Opin Support Palliat Care. 2021. PMID: 34762073 Review.
-
Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.Treat Respir Med. 2004;3(4):247-68. doi: 10.2165/00151829-200403040-00005. Treat Respir Med. 2004. PMID: 15350163 Review.
Cited by
-
Medical hypnosis mitigates laboratory dyspnoea in healthy humans: a randomised, controlled experimental trial.Eur Respir J. 2024 Sep 12;64(3):2400485. doi: 10.1183/13993003.00485-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 38991710 Free PMC article. Clinical Trial.
-
Limitations of a 6-min walk test to assess the efficacy of menthol for breathlessness.ERJ Open Res. 2022 May 9;8(2):00090-2022. doi: 10.1183/23120541.00090-2022. eCollection 2022 Apr. ERJ Open Res. 2022. PMID: 35539436 Free PMC article.
-
Distinguishing science from pseudoscience in commercial respiratory interventions: an evidence-based guide for health and exercise professionals.Eur J Appl Physiol. 2023 Aug;123(8):1599-1625. doi: 10.1007/s00421-023-05166-8. Epub 2023 Mar 14. Eur J Appl Physiol. 2023. PMID: 36917254 Free PMC article. Review.
-
Short-term effects of menthol on walking dyspnoea in patients with COPD: a randomised, single blinded, cross-over study.ERJ Open Res. 2021 Oct 25;7(4):00450-2021. doi: 10.1183/23120541.00450-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34708112 Free PMC article.
-
ERS International Congress 2023: highlights from the Allied Respiratory Professionals Assembly.ERJ Open Res. 2024 Mar 25;10(2):00889-2023. doi: 10.1183/23120541.00889-2023. eCollection 2024 Mar. ERJ Open Res. 2024. PMID: 38529350 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Medical